RCKT - Rocket Pharmaceuticals Inc

Exchange: NASDAQ

RCKT - Rocket Pharmaceuticals Inc

Exchange: NASDAQ

Tue 18'th Sep 2018

PERIOD 2018-06-19 - 2018-09-18
CHANGE 2.33%
PRICE $22.79





Request Prediction

Rocket Pharmaceuticals Inc Stock Analysis

Technical stock analysis for Tue 18'th Sep 2018

Buy candidate since 2018-09-10 Loss -7.06%
Shorts 19.60% ( 2018-08-31 )
Cash n/a
Loans n/a
Beta 3.97
ROA -33.88

Rocket Pharmaceuticals Inc gained 2.33% in the last trading day, rising from $22.27 to $22.79 The price has fallen in 6 of the last 10 days and is down by -3.51% for this period. Volume fell in the last day by -234 194 shares, and in total, 152 210 shares bought and sold for approximately $3.47 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.


Rocket Pharmaceuticals Inc lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 17.96% during the next 3 months and, with 90% probability hold a price between $24.56 and $30.29 at the end of this period.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Rocket Pharmaceuticals Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $24.00. On a fall, the stock will find some support from the long-term average at approximately $22.09. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Monday September 17, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 53 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $20.87 and $20.61.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Rocket Pharmaceuticals Inc finds support just below today's level at $20.87. If this is broken, then the next support from accumulated volume will be at $20.61 and $20.42.

Support: $20.87 Price: $22.79 Resistance: $24.44


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.77 between high and low, or 3.46%. For the last week, the stock has had a daily average volatility of 7.08%.

Our recommended stoploss: $21.59 (-5.27%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy Candidate

Click for Top 5 Buy Candidates
RCKT $22.79 $0.52(2.33%)
RCKT is up $0.52 today, but where's it headed in October?
Zacks Investment Research is releasing its prediction for RCKT based on the 1-3 month system that more than doubles the S&P 500.

Click here – the RCKT analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with